Cover Image

Neuro-oncology management during the COVID-19 pandemic with a focus on WHO grades III and IV gliomas

Because of the increased risk in cancer patients of developing complications caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), physicians have to balance the competing risks of the negative impact of the pandemic and the primary tumor disease. In this consensus statement, an in...

Full description

Saved in:
Bibliographic Details
Main Authors: Bernhardt, Denise (Author) , Wick, Wolfgang (Author) , Weiss, Stephanie E (Author) , Sahgal, Arjun (Author) , Lo, Simon S (Author) , Suh, John H (Author) , Chang, Eric L (Author) , Foote, Matthew (Author) , Perry, James (Author) , Meyer, Bernhard (Author) , Vajkoczy, Peter (Author) , Wen, Patrick Y (Author) , Straube, Christoph (Author) , Pigorsch, Steffi (Author) , Wilkens, Jan J (Author) , Combs, Stephanie E (Author)
Format: Article (Journal)
Language:English
Published: 5 May 2020
In: Neuro-Oncology
Year: 2020, Volume: 22, Issue: 7, Pages: 928-935
ISSN:1523-5866
DOI:10.1093/neuonc/noaa113
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/neuonc/noaa113
Get full text
Author Notes:Denise Bernhardt, Wolfgang Wick, Stephanie E Weiss, Arjun Sahgal, Simon S Lo, John H Suh, Eric L Chang, Matthew Foote, James Perry, Bernhard Meyer, Peter Vajkoczy, Patrick Y Wen, Christoph Straube, Steffi Pigorsch, Jan J Wilkens, and Stephanie E Combs
Description
Summary:Because of the increased risk in cancer patients of developing complications caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), physicians have to balance the competing risks of the negative impact of the pandemic and the primary tumor disease. In this consensus statement, an international group of experts present mitigation strategies and treatment guidance for patients suffering from high grade gliomas (HGGs) during the coronavirus disease 2019 (COVID-19) pandemic.international experts in the treatment of HGG contributed to this consensus-based practice recommendation, including neuro-oncologists, neurosurgeons, radiation oncologists, and a medical physicist. Generally, treatment of neuro-oncological patients cannot be significantly delayed and initiating therapy should not be outweighed by COVID-19. We present detailed interdisciplinary treatment strategies for molecular subgroups in 2 pandemic scenarios, a scale-up phase and a crisis phase.This practice recommendation presents a pragmatic framework and consensus-based mitigation strategies for the treatment of HGG patients during the SARS-CoV-2 pandemic.
Item Description:Gesehen am 05.02.2021
Physical Description:Online Resource
ISSN:1523-5866
DOI:10.1093/neuonc/noaa113

Similar Items